Atorvastatin has antithrombotic effects in patients with type 1 diabetes and dyslipidemia

Thrombosis Research
Sara TehraniG Jörneskog

Abstract

Diabetes is a prothrombotic state involving a more thrombogenic fibrin network. In the present study we investigated the effects of lipid-lowering therapy with atorvastatin on fibrin network structure and platelet-derived microparticles in patients with type 1 diabetes and dyslipidemia. Twenty patients were treated with atorvastatin (80 mg daily) or placebo during 2 months in a randomized, double-blind, cross-over study. Fibrin network permeability, expression of glycoprotein IIIa, P-selectin and tissue factor on platelet-derived microparticles, plasma endogenous thrombin potential, plasminogen activator inhibitor-1 and tissue plasminogen activator antigen levels were assessed. Additionally, levels of plasma fibrinogen, high-sensitivity C-reactive protein and glycated haemoglobin were measured. During treatment with atorvastatin, fibrin network permeability increased (p=0.01), while endogenous thrombin potential and expression of glycoprotein IIIa, P-selectin and tissue factor decreased (p<0.01). In vitro experiments indicated that platelet-derived microparticles influence the fibrin network formation as fibrin network permeability decreased significantly when platelet-derived microparticles were added to normal plasma. Baselin...Continue Reading

References

Jul 27, 1989·Biochimica Et Biophysica Acta·B BlombäckN Aslund
Jan 1, 1982·Thrombosis Research·B Blombäck, M Okada
Dec 1, 1996·Diabetologia·G JörneskogM Blombäck
Dec 18, 2004·Blood·Saulius ButenasKenneth G Mann
Feb 19, 2005·Diabetic Medicine : a Journal of the British Diabetic Association·G K DograK Stanton
Jun 11, 2005·Journal of Thrombosis and Haemostasis : JTH·D W SommeijerH ten Cate
Sep 9, 2005·Seminars in Thrombosis and Hemostasis·Kerstin Jurk, Beate E Kehrel
Feb 16, 2006·Seminars in Thrombosis and Hemostasis·Bjarne Østerud, Eirik Bjørklid
Nov 30, 2006·Psychosomatic Medicine·Petra H WirtzRoland von Känel
Mar 10, 2007·Blood·Olga PanesDiego Mezzano
Aug 1, 2007·Journal of Thrombosis and Haemostasis : JTH·J W Weisel
Nov 11, 2008·The New England Journal of Medicine·Paul M RidkerUNKNOWN JUPITER Study Group
Mar 31, 2009·The New England Journal of Medicine·Robert J GlynnPaul M Ridker
Nov 27, 2009·Thrombosis Research·Fariborz MobarrezHåkan Wallén

❮ Previous
Next ❯

Citations

May 7, 2014·Current Diabetes Reports·Petter Bjornstad, R Paul Wadwa
Jan 17, 2015·Chinese Medical Journal·Bo-Da ZhouWei Gao
Jul 14, 2012·Current Diabetes Reports·Bernd BaumannBernhard O Boehm
Dec 5, 2015·Scientific Reports·Laily D ZubairovaJohn W Weisel
May 27, 2011·Thrombosis and Haemostasis·Silvia Montoro-GarcíaEduard Shantsila
Jul 17, 2013·Journal of Thrombosis and Haemostasis : JTH·R A S Ariëns
Apr 10, 2013·Journal of Thrombosis and Haemostasis : JTH·N B AdamsM Cushman
Nov 5, 2011·Journal of Cellular and Molecular Medicine·Morgane BaronAnne Tailleux
Mar 19, 2014·Thrombosis Research·Anna VikerforsAleksandra Antovic
Sep 26, 2013·Scandinavian Journal of Clinical and Laboratory Investigation·Elisabeth RoothHåkan Wallén
Aug 21, 2013·Journal of the American College of Cardiology·Dimitris TousoulisChristodoulos Stefanadis
Jan 12, 2013·Blood·John W Weisel, Rustem I Litvinov
Sep 24, 2015·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Tora AlmquistPaul Hjemdahl
Nov 23, 2017·Cardiovascular Drugs and Therapy·Justyna RosińskaWojciech Kozubski
Jan 13, 2018·Frontiers in Cardiovascular Medicine·Lina BadimonTeresa Padró
Aug 13, 2011·Arteriosclerosis, Thrombosis, and Vascular Biology·Anetta Undas, Robert A S Ariëns
Apr 23, 2019·Annals of Medicine·Christos VoukalisGregory Y H Lip
Nov 23, 2011·Pharmacological Reviews·Patrizia GazzerroMaurizio Bifulco
Apr 27, 2012·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Aaron M SecrestTrevor J Orchard
Jul 5, 2013·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Sara TehraniGun Jörneskog
Jun 1, 2018·Journal of the Endocrine Society·Jacob C HartzSamuel Gidding
Oct 18, 2018·Therapeutic Advances in Endocrinology and Metabolism·Rawan Mohammad Al SaudiYasser Bustanji
Jan 23, 2021·The Cochrane Database of Systematic Reviews·Muhammad Ismail ShawishJames M Wright
Jan 24, 2021·Cardiovascular Research·Wern Yew DingGregory Y H Lip

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.